This Tech Megatrend Isn’t on Wall Street’s Radar
While tech stocks have been hit hard by the recent sell-off, Jeff Brown believes we’ll see this sector rally...
Page 183
The Bleeding Edge
Sign-up for hard-hitting research on hot growth stocks, wild new developments, and the inner workings of the high-tech industry. Every weekday at 4:00 pm ET
CRISPR Is Now Targeting Vitamin Deficiencies
CRISPR is like software programming for DNA, and U.K.-based researchers just demonstrated how to use it to stop tomatoes...
A New Strategy for This Volatile Market
With the potential for more aggressive interest-rate hikes and rising inflation, it makes sense to approach this market with...
DeSoc Whitepaper Could Lead to China-Style Social Credits
A recent Bleeding Edge topic, DeSoc, would provide a way to document and validate our key credentials. But our...
“Real” Inflation Is Much Higher Than the CPI
Volatility is scaring investors away from potentially groundbreaking investments, so where should we turn next? Jeff Brown has been...
TSMC’s CapEx Is Hitting Record Levels
With all of the fear in the market, Jeff has been keeping a close eye on indicators that allow...